Exact Sciences Corporation (BIT:1EXAS)
Italy
· Delayed Price · Currency is EUR 48.37
+1.13 (2.40%)
At close: May 13, 2025
Exact Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 2,828 | 2,759 | 2,500 | 2,084 | 1,767 | 1,491 | Upgrade
|
| Revenue Growth (YoY) | 11.57% | 10.37% | 19.93% | 17.95% | 18.49% | 70.19% | Upgrade
|
| Cost of Revenue | 855.19 | 840.15 | 737.56 | 661.36 | 458.76 | 354.32 | Upgrade
|
| Gross Profit | 1,973 | 1,919 | 1,762 | 1,423 | 1,308 | 1,137 | Upgrade
|
| Selling, General & Admin | 1,717 | 1,673 | 1,610 | 1,536 | 1,538 | 1,071 | Upgrade
|
| Research & Development | 425.65 | 431.21 | 426.93 | 394.19 | 385.65 | 554.05 | Upgrade
|
| Other Operating Expenses | - | - | -2.03 | 13.24 | - | - | Upgrade
|
| Operating Expenses | 2,143 | 2,104 | 2,035 | 1,944 | 2,019 | 1,719 | Upgrade
|
| Operating Income | -170.2 | -185.1 | -272.75 | -520.93 | -710.57 | -581.7 | Upgrade
|
| Interest Expense | -29.05 | -27.02 | -19.45 | -19.63 | -18.61 | -67.94 | Upgrade
|
| Interest & Investment Income | 38.34 | 39.56 | 32.71 | - | 31.78 | 6.57 | Upgrade
|
| EBT Excluding Unusual Items | -160.9 | -172.56 | -259.48 | -540.56 | -697.4 | -643.06 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -117.7 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -19.43 | - | - | Upgrade
|
| Asset Writedown | -871.27 | -869.46 | -0.62 | -15.97 | -20.21 | -209.67 | Upgrade
|
| Other Unusual Items | 3.44 | 5.86 | 58.36 | -56.62 | -7.2 | 23.67 | Upgrade
|
| Pretax Income | -1,029 | -1,036 | -201.75 | -632.57 | -842.51 | -829.06 | Upgrade
|
| Income Tax Expense | -8.89 | -7.3 | 2.4 | -9.06 | -246.88 | -5.46 | Upgrade
|
| Net Income | -1,020 | -1,029 | -204.15 | -623.51 | -595.63 | -823.61 | Upgrade
|
| Net Income to Common | -1,020 | -1,029 | -204.15 | -623.51 | -595.63 | -823.61 | Upgrade
|
| Shares Outstanding (Basic) | 185 | 184 | 180 | 176 | 171 | 151 | Upgrade
|
| Shares Outstanding (Diluted) | 185 | 184 | 180 | 176 | 171 | 151 | Upgrade
|
| Shares Change (YoY) | 2.33% | 2.25% | 2.15% | 2.92% | 13.37% | 15.15% | Upgrade
|
| EPS (Basic) | -5.50 | -5.59 | -1.13 | -3.54 | -3.48 | -5.45 | Upgrade
|
| EPS (Diluted) | -5.51 | -5.59 | -1.13 | -3.54 | -3.48 | -5.45 | Upgrade
|
| Free Cash Flow | 194.14 | 74.55 | 31.93 | -438.02 | -238 | 71.4 | Upgrade
|
| Free Cash Flow Per Share | 1.05 | 0.41 | 0.18 | -2.48 | -1.39 | 0.47 | Upgrade
|
| Gross Margin | 69.76% | 69.55% | 70.49% | 68.27% | 74.04% | 76.24% | Upgrade
|
| Operating Margin | -6.02% | -6.71% | -10.91% | -24.99% | -40.21% | -39.00% | Upgrade
|
| Profit Margin | -36.06% | -37.29% | -8.17% | -29.92% | -33.71% | -55.22% | Upgrade
|
| Free Cash Flow Margin | 6.87% | 2.70% | 1.28% | -21.02% | -13.47% | 4.79% | Upgrade
|
| EBITDA | 44.78 | 29.76 | -66.14 | -323.37 | -530.22 | -418.33 | Upgrade
|
| EBITDA Margin | 1.58% | 1.08% | -2.65% | -15.51% | -30.00% | -28.05% | Upgrade
|
| D&A For EBITDA | 214.98 | 214.86 | 206.61 | 197.56 | 180.35 | 163.36 | Upgrade
|
| EBIT | -170.2 | -185.1 | -272.75 | -520.93 | -710.57 | -581.7 | Upgrade
|
| EBIT Margin | -6.02% | -6.71% | -10.91% | -24.99% | -40.21% | -39.00% | Upgrade
|
| Advertising Expenses | - | 180.3 | 137.9 | 170.3 | 144 | 97.6 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.